Agilon Health, Inc. AGL
Institutional shares held
399 Million
2.72M
calls
2.36M
puts
Total value of holdings
$787M
$5.36M
calls
$4.66M
puts
Market Cap
$810M
410,936,000
Shares Out.
Institutional ownership
97.21%
# of Institutions
242
We take great care to ensure that the data presented and summarized in this overview for agilon health, inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding AGL
View all-
Clayton, Dubilier & Rice, LLC100MShares$197 Million97.86% of portfolio
-
Morgan Stanley New York, NY56.2MShares$111 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA52.9MShares$104 Million0.04% of portfolio
-
Capital World Investors Los Angeles, CA48.4MShares$95.3 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA30.8MShares$60.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY23.2MShares$45.7 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA13MShares$25.6 Million0.01% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD9.1MShares$17.9 Million1.22% of portfolio
-
State Street Corp Boston, MA7.45MShares$14.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA6.89MShares$13.6 Million0.0% of portfolio
Latest Institutional Activity in AGL
Top Purchases
Top Sells
About AGL
agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.
Insider Transactions at AGL
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 13
2024
|
Karen Mc Loughlin Director |
BUY
Open market or private purchase
|
Direct |
25,000
+25.47%
|
$50,000
$2.2 P/Share
|
|
Dec 11
2024
|
Silvana Battaglia Director |
BUY
Open market or private purchase
|
Direct |
25,062
+27.48%
|
$50,124
$2.01 P/Share
|
|
Dec 09
2024
|
Diana Mckenzie Director |
BUY
Open market or private purchase
|
Direct |
7,500
+11.31%
|
$15,000
$2.2 P/Share
|
|
Dec 05
2024
|
John William Wulf Director |
BUY
Open market or private purchase
|
Direct |
45,000
+17.92%
|
$90,000
$2.18 P/Share
|
|
Nov 25
2024
|
Diana Mckenzie Director |
BUY
Open market or private purchase
|
Direct |
12,500
+19.59%
|
$25,000
$2.28 P/Share
|
|
Sep 12
2024
|
Steven Sell CEO & President |
BUY
Open market or private purchase
|
Indirect |
20,000
+22.83%
|
$60,000
$3.36 P/Share
|
|
Aug 16
2024
|
Timothy Gertsch Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
405
-0.69%
|
$1,620
$4.85 P/Share
|
|
Jul 01
2024
|
Jeffrey A. Schwaneke Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
659,880
+27.35%
|
-
|
|
May 29
2024
|
Silvana Battaglia Director |
BUY
Grant, award, or other acquisition
|
Direct |
32,119
+43.88%
|
-
|
|
May 29
2024
|
Sharad Mansukani Director |
BUY
Grant, award, or other acquisition
|
Direct |
32,119
+2.46%
|
-
|
|
May 29
2024
|
Jeffrey A. Schwaneke Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
32,119
+33.4%
|
-
|
|
May 29
2024
|
John William Wulf Director |
BUY
Grant, award, or other acquisition
|
Direct |
32,119
+16.62%
|
-
|
|
May 29
2024
|
Karen Mc Loughlin Director |
BUY
Grant, award, or other acquisition
|
Direct |
32,119
+40.01%
|
-
|
|
May 29
2024
|
Diana Mckenzie Director |
BUY
Grant, award, or other acquisition
|
Direct |
32,119
+45.28%
|
-
|
|
May 29
2024
|
Ronald A Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
32,119
+0.89%
|
-
|
|
May 24
2024
|
Timothy Gertsch Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
187
-0.32%
|
$1,122
$6.09 P/Share
|
|
Apr 15
2024
|
Girish Venkatachaliah Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
112,108
+42.44%
|
-
|
|
Apr 15
2024
|
Timothy Gertsch Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
42,041
+41.54%
|
-
|
|
Apr 15
2024
|
Steven Sell CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
252,243
+42.86%
|
-
|
|
Apr 15
2024
|
Veeral Desai Chief Strategy & Dev. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
196,189
+28.07%
|
-
|
Last 12 Months Summary
Buy / Acquisition
3.23M
Shares
From
23
Insiders
| Grant, award, or other acquisition | 1.68M shares |
|---|---|
| Exercise of conversion of derivative security | 1.1M shares |
| Open market or private purchase | 447K shares |
Sell / Disposition
137K
Shares
From
7
Insiders
| Payment of exercise price or tax liability | 137K shares |
|---|